{"id":1112,"date":"2023-10-05T04:44:45","date_gmt":"2023-10-05T02:44:45","guid":{"rendered":"https:\/\/www.survi.fr\/?page_id=1112"},"modified":"2024-10-08T14:53:12","modified_gmt":"2024-10-08T12:53:12","slug":"homepage","status":"publish","type":"page","link":"https:\/\/www.survi.fr\/en\/","title":{"rendered":"Homepage"},"content":{"rendered":"\n
In 2016<\/strong> the 1st<\/sup> Intestinal Vascular Emergency Structure<\/strong> (S<\/strong>tructure d\u2019UR<\/strong>gences V<\/strong>asculaires I<\/strong>ntestinales – SURVI<\/strong>) was established at APHP<\/strong>, within the Bichat<\/strong> and Beaujon<\/strong> hospitals, specifically dedicated to the management of intestinal ischemia and vascular diseases<\/strong>. Following the model of Stroke Centers and Cardiology Intensive Care Units SURVI<\/strong> aims to improve the catastrophic prognosis of mesenteric infarction.\u00a0<\/p>\n\n\n\n The therapeutic strategy of SURVI<\/strong>, developed by Professor Olivier Corcos<\/strong>, focuses on preserving intestinal viability and utilizes a multidisciplinary, case-by-case approach. It involves collaboration between gastroenterologists specializing in vascular digestive diseases, vascular surgeons, interventional radiologists, digestive surgeons, anesthesiologists-intensivists, and cardiologists.<\/p>\n\n\n\n